OIA
PDLI

Optimum Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Optimum Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$14K Hold
2,000
– – ﹤0.01% 762
2014
Q4 		$15K Hold
2,000
– – ﹤0.01% 790
2014
Q3 		$16K Hold
2,000
– – 0.01% 691
2014
Q2 		$19K Buy
+2,000
New +$17.8K 0.01% 675

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Optimum Investment Advisors's PDLI Position: Q1 2015 in Review

Optimum Investment Advisors held its PDL BioPharma, Inc. (PDLI) position steady in Q1 2015 at 2,000 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Optimum Investment Advisors first reported a position in PDLI in Q2 2014 and has held it in 4 quarters since. The position peaked at $19K in Q2 2014. 215 funds tracked by Wall St. Rank hold PDLI as of Q1 2015.

  • Optimum Investment Advisors held 2,000 shares of PDL BioPharma, Inc. worth $14K as of Q1 2015.
  • Optimum Investment Advisors left its PDL BioPharma, Inc. share count unchanged in Q1 2015.
  • PDL BioPharma, Inc. made up ﹤0.01% of Optimum Investment Advisors's portfolio in Q1 2015, its #762 holding.
  • Optimum Investment Advisors first reported a position in PDL BioPharma, Inc. in Q2 2014 and has held it in 4 quarters since.
  • Optimum Investment Advisors's PDL BioPharma, Inc. position peaked at $19K in Q2 2014.
  • 215 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2015.

Based on Optimum Investment Advisors's 13F filing for Q1 2015, filed 18 May 2015.